NET PROFIT (x1000 EUR)
EMPLOYEES
Active Biotech AB (publ)
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
18
|
21
|
48 |
| Earnings before taxes |
-3,430
|
-4,128
|
-5,245 |
| EBITDA |
-3,469
|
-4,189
|
-5,202 |
| Total assets |
3,760
|
3,970
|
4,583 |
| Current assets |
3,414
|
3,489
|
3,965 |
| Current liabilities |
776
|
935
|
1,084 |
| Equity capital |
2,851
|
2,764
|
3,101 |
| - share capital |
553
|
168
|
123 |
| Employees (average) |
7
|
8
|
9 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
75.8%
|
69.6%
|
67.7% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-90.7%
|
-103.5%
|
-113.4% |
| Current ratio |
439.9%
|
373.2%
|
365.8% |
| Return on equity (ROE) |
-120.3%
|
-149.3%
|
-169.1% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
-1
|
-1
|
1 |
| Chg. No. of employees % |
-13%
|
-11%
|
13% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.